Bezafibrate Tablet

Bezafibrate Tablet

Categories : Cardiovascular System

Product Packaging : 10 / 30 tablets

Product Composition : 200 mg

Send Message

Bezafibrate Tablets are lipid-regulating medicines commonly utilized for hypertriglyceridemia treatment, dyslipidemia management, and improvement of abnormal lipid profile conditions associated with cardiovascular risk factors.

The formulation contains Bezafibrate, a fibrate class medicine that helps reduce triglyceride levels while supporting HDL cholesterol improvement and balanced lipid metabolism in patients requiring long-term lipid management therapy.

Genliva Wellness LLP manufactures these formulations as a Bezafibrate Tablets Manufacturer in India, while also operating as a Triglyceride Lowering Medicine Exporter and Dyslipidemia Treatment Tablets Supplier for pharmaceutical distributors, cardiovascular healthcare programs, and regulated international pharmaceutical markets.

Bezafibrate Tablets are formulated for lipid and triglyceride management therapy.

  • Oral fibrate lipid-regulating formulation
  • Frequently utilized in triglyceride management
  • Supports healthy lipid metabolism balance
  • Helps improve abnormal lipid profile conditions
  • Manufactured using quality pharmaceutical ingredients
  • Intended for long-term lipid therapy programs

This formulation is prescribed in lipid management therapies.

  • Treatment of hypertriglyceridemia conditions
  • Management of dyslipidemia disorders
  • Administered in cholesterol control therapies
  • Utilized in cardiovascular risk reduction programs
  • Helps support healthy lipid profile management

Bezafibrate Tablets deliver fibrate therapy support for lipid management care.

  • Valuable in triglyceride reduction therapies
  • Frequently preferred in dyslipidemia management
  • Effective lipid regulation therapy support
  • Useful in long-term cholesterol management
  • Convenient oral fibrate administration
  • Maintains reliable lipid control performance

whatsapp-app